Dreicer, R., & Carducci, M. (2003). E-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone with Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer Patients with Rising PSA Levels. MedReviews, LLC.
Chicago-tyylinen lähdeviittausDreicer, Robert, ja Michael Carducci. E-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone With Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer Patients With Rising PSA Levels. MedReviews, LLC, 2003.
MLA-viiteDreicer, Robert, ja Michael Carducci. E-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone With Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer Patients With Rising PSA Levels. MedReviews, LLC, 2003.